Greater FDA Transparency Could Benefit Industry, Too, Trade Reps Say
This article was originally published in The Gray Sheet
Executive Summary
Despite concerns with maintaining trade secret protections, industry has much to gain from increased openness by FDA, device industry representatives said at a June 24 meeting of FDA's new Transparency Task Force